Back to Journals » Journal of Pain Research » Volume 13

Population Pharmacokinetic Modeling of Flurbiprofen, the Active Metabolite of Flurbiprofen Axetil, in Chinese Patients with Postoperative Pain [Corrigendum]

Authors Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H

Received 27 February 2020

Accepted for publication 27 February 2020

Published 18 March 2020 Volume 2020:13 Pages 553—554

DOI https://doi.org/10.2147/JPR.S251590



Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H. J Pain Res. 2018;11:3061– 3070.

Correction for “Population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen axetil, in Chinese patients with postoperative pain” Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H. Journal of Pain Research.  2018;11:3061– 3070.

The above article published in the Journal of Pain Research was under investigation for allegedly reporting results from an unrelated study using an unrelated clinical trial registration (CTR) number. We previously published an Expression of Concern to highlight this to readers while we completed our investigation:

Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H. Journal of Pain Research. 2019;12:2799. https://doi.org/10.2147/JPR. S231531.
 
Read the original article



Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]